Filing Details
- Accession Number:
- 0001171843-14-001374
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-21 09:16:53
- Reporting Period:
- 2014-03-18
- Filing Date:
- 2014-03-21
- Accepted Time:
- 2014-03-21 09:16:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1365216 | Sucampo Pharmaceuticals Inc. | SCMP | Pharmaceutical Preparations (2834) | 133929237 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1383377 | R Gayle Dolecek | 4520 East West Hwy, 3Rd Floor Bethesda MD 20814 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2014-03-18 | 1,200 | $4.41 | 1,200 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2014-03-18 | 1,200 | $8.03 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2014-03-18 | 1,200 | $0.00 | 1,200 | $4.41 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
313,367 | 2013-05-02 | 2021-05-02 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the reporting person on June 13, 2013.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.07, inclusive. The reporting person undertakes to provide Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.